AAB - Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis

Product Lines:
Advantage MD, EHP, Priority Partners and USFHP.

Eligible Population:
Members 3 months and older by December 31 of the measurement year.

Definition:
Percentage of episodes for members ages 3 months and older with a diagnosis of acute bronchitis/bronchiolitis, who were not dispensed an antibiotic medication on or 3 days after the episode. Looks at episodes for any outpatient, telephone, observation or ED visit, e-visit or virtual check-in during the intake period with a diagnosis of acute bronchitis/bronchiolitis, between July 1 of the year prior to the measurement year through June 30 of the measurement year. The measure is reported as an inverted rate: A higher rate indicates appropriate treatment (not prescribed an antibiotic).

Report three age stratifications and a total rate: 

  • 3 months–17 years. 
  • 18–64 years.
  • 65 years and older. 
  • Total. The total is the sum of the age stratifications. 

Continuous Enrollment:

  • 30 days prior to the episode date through 3 days after the episode date (34 total days).

Best Practice and Measure Tips

  • Avoid prescribing an antibiotic unless there is a bacterial etiology.
  • When antibiotics are needed for a patient with acute bronchitis / bronchiolitis with comorbid conditions: submit codes on the same claim to remove member from measure.
    • Examples:  HIV, Malignant Neoplasm, Emphysema, COPD 
  • An episode will not count toward the measure denominator if the member was diagnosed with pharyngitis or a competing diagnosis, if the visit resulted in an inpatient stay on or 3 days after the episode date.
  • Not exclusions for this HEDIS measure: asthma and diabetes diagnosis; Symptoms such as fever, cough and wheezing; tobacco use.
  • This measure is based on episodes; members may have multiple episodes. 
  • CDC offers a number of materials and tools about antibiotic resistance, appropriate prescribing and use for common infections.
  • Telehealth visits are allowed for this measure.  

Measure Exclusions

  • Members in hospice or using hospice services anytime during the measurement year.  
  • Members who died any time during the measurement year. 

Measure Codes

Diagnosis of acute bronchitis/bronchiolitis (Acute Bronchitis Value Set): J20.3-J20.9, J21.0, J21.1, J21.8, J21.9 

Measure Medications

To comply with this measure, episode dates will not count where a new or refill prescription for an antibiotic medication (AAB Antibiotic Medications List) was dispensed 30 days prior to the episode date or was active on the episode date. Otherwise, a dispensed prescription for any of below medication on or 3 days after the episode date, will count.

Description Prescription
Aminoglycosides
  • Amikacin
  • Gentamicin
  • Streptomycin
  • Tobramycin
Aminopenicillins
  • Amoxicillin
  • Ampicillin
Beta-lactamase inhibitors
  • Amoxicillin-clavulanate
  • Ampicillin-sulbactam
  • Piperacillin-tazobactam
First-generation cephalosporins
  • Cefadroxil
  • Cefazolin
  • Cephalexin
Fourth-generation cephalosporins
  • Cefepime
Lincomycin derivatives
  • Clindamycin
  • Lincomycin
Macrolides
  • Azithromycin
  • Clarithromycin
  • Erythromycin
Miscellaneous antibiotics
  • Penicillin G benzathine-procaine
  • Penicillin G potassium
  • Penicillin G procaine
  • Penicillin G sodium
  • Penicillin V potassium
  • Penicillin G benzathine
Penicillinase resistant penicillins
  • Dicloxacillin
  • Nafcillin
  • Oxacillin
Quinolones
  • Ciprofloxacin
  • Gemifloxacin
  • Levofloxacin
  • Moxifloxacin
  • Ofloxacin
Rifamycin derivatives
  • Rifampin
Second-generation cephalosporin
  • Cefaclor
  • Cefotetan
  • Cefoxitin
  • Cefprozil
  • Cefuroxime
Sulfonamides
  • Sulfadiazine
  • Sulfamethoxazole-trimethoprim
Tetracyclines
  • Doxycycline
  • Minocycline
  • Tetracycline
Third-generation cephalosporins
  • Cefdinir
  • Cefixime
  • Cefotaxime
  • Cefpodoxime
  • Ceftazidime
  • Ceftriaxone
Urinary anti-infectives
  • Fosfomycin
  • Nitrofurantoin
  • Nitrofurantoin macrocrystals-monohydrate
  • Trimethoprim